Early reports of TNF-alpha inhibitor use to control AF lesions involved patients with SAPHO syndrome (Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis) who had failed conventional treatments.3 Here, TNF is linked to hyperostosis.